http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2001612-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85ac5ddde718501222eb2f0fbda19dc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6eff2d87414496b09bb38a7357dff005
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
filingDate 1991-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1993-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78762e3c7cb456eb401800ae868e27a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbe0756e96927b1fc93d0f1eb20f7753
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_779b8e43dea4bdb05ca8d820f3acf7dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2851c17329671a0be47cf600162b30a
publicationDate 1993-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2001612-C1
titleOfInvention Method for postoperative adhesive sickness prophylaxis
abstract The invention relates to medicine, in particular to surgery. The purpose of the invention is to increase the effectiveness of prevention by reducing the number of relapses and shortening the treatment time. For this, 100-120 ml of a 20% solution of mannitol containing 5-10 mg methotrexate are injected into the subcutaneous lymph vessel at a rate of 5-6 ml / h every other day for 10-15 days. after operation..
priorityDate 1991-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503607
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491720
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507566
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2726
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1979
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507158
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799

Total number of triples: 49.